Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 4, 2008 - Issue 6
Submit an article Journal homepage
40
Views
16
CrossRef citations to date
0
Altmetric
Expert Opinion

Mycophenolate mofetil for myasthenia gravis: a clear and present controversy

Chad HeatwoleDepartment of Neurology, The University of Rochester, Rochester, New York, USACorrespondence[email protected]
&
Emma CiafaloniDepartment of Neurology, The University of Rochester, Rochester, New York, USA
Pages 1203-1209 | Published online: 05 Dec 2008

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Eduardo Monguilhott Dalmarco, Caio Maurício Mendes de Córdova & Tânia Silvia Fröde. (2011) Evidence of an anti-inflammatory effect of mycophenolate mofetil in a murine model of pleurisy. Experimental Lung Research 37:7, pages 399-407.
Read now

Articles from other publishers (15)

Aiswarya Binu, Sarath S. Kumar, Uma Devi Padma & Krishnadas Madhu. (2022) Pathophysiological basis in the management of myasthenia gravis: a mini review. Inflammopharmacology 30:1, pages 61-71.
Crossref
Swathi Beladakere Ramaswamy, Shivangi Singh, Sara Hooshmand, Cho Junsang, Megan Sweeney & Raghav Govindarajan. (2021) Current and Upcoming Treatment Modalities in Myasthenia Gravis. Journal of Clinical Neuromuscular Disease 23:2, pages 75-99.
Crossref
Abigail Koehler, Aniruddha Karve, Pankaj Desai, Jack Arbiser, David R. Plas, Xiaoyang Qi, Renee D. Read, Atsuo T. Sasaki, Vaibhavkumar S. Gawali, Donatien K. Toukam, Debanjan Bhattacharya, Laura Kallay, Daniel A. Pomeranz Krummel & Soma Sengupta. (2021) Reuse of Molecules for Glioblastoma Therapy. Pharmaceuticals 14:2, pages 99.
Crossref
Griselda Lim Loo Xin, Yap Pui Khee, Tan Yoke Ying, Jestin Chellian, Gaurav Gupta, Anil Philip Kunnath, Srinivas Nammi, Trudi Collet, Philip Michael Hansbro, Kamal Dua & Dinesh Kumar Chellappan. (2019) Current Status on Immunological Therapies for Type 1 Diabetes Mellitus. Current Diabetes Reports 19:5.
Crossref
Margherita Nosadini, Jonathan Gadian, Ming Lim, Stefano Sartori, Terrence Thomas & Russell C Dale. (2018) Mycophenolate mofetil in paediatric autoimmune or immune‐mediated diseases of the central nervous system: clinical experience and recommendations. Developmental Medicine & Child Neurology 61:4, pages 458-468.
Crossref
Saiju Jacob. (2018) Myasthenia Gravis – A Review of Current Therapeutic Options. European Neurological Review 13:2, pages 86.
Crossref
Björn Oskarsson, David M. Rocke, Karsten Dengel & David P. Richman. (2016) Myasthenia gravis exacerbation after discontinuing mycophenolate. Neurology 86:12, pages 1159-1163.
Crossref
Jan Verschuuren, Ellen Strijbos & Angela Vincent. 2016. Autoimmune Neurology. Autoimmune Neurology 447 466 .
Daniel Bell & Henry Knipe. 2005. Radiopaedia.org. Radiopaedia.org.
Katherine A. Buzzard, Nicholas J. Meyer, Todd A. Hardy, D. Sean Riminton & Stephen W. Reddel. (2015) Induction intravenous cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis. Muscle & Nerve 52:2, pages 204-210.
Crossref
Henry J. Kaminski. 2014. Neuromuscular Disorders in Clinical Practice. Neuromuscular Disorders in Clinical Practice 1075 1088 .
M. G. Beduschi, C. L. Guimarães, Z. S. Buss & E. M. Dalmarco. (2013) Mycophenolate Mofetil Has Potent Anti-inflammatory Actions in a Mouse Model of Acute Lung Injury. Inflammation 36:3, pages 729-737.
Crossref
Eduardo Monguilhott Dalmarco, Giliard Astolfi, Rafael de Liz, Caio Maurício Mendes de Córdova & Tânia Silvia Fröde. (2012) Modulatory effect of mycophenolate mofetil on carrageenan-induced inflammation in the mouse air pouch model. International Immunopharmacology 13:4, pages 476-482.
Crossref
Joseph R. Berger. (2010) Progressive Multifocal Leukoencephalopathy and Newer Biological Agents. Drug Safety 33:11, pages 969-983.
Crossref
Mohamed-Eslam F. Mohamed & Reginald F. Frye. (2010) Inhibition of Intestinal and Hepatic Glucuronidation of Mycophenolic Acid by Ginkgo biloba Extract and Flavonoids. Drug Metabolism and Disposition 38:2, pages 270-275.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.